Baricitinib and the Risk of Incident Interstitial Lung Disease: A Descriptive Clinical Case Report from Clinical Trials

OBJECTIVES: Interstitial lung disease (ILD) occurs in up to 30% of patients with rheumatoid arthritis (RA), resulting in increased morbidity and death in the absence of proven therapies. The aim of this study is to estimate the number of incident ILD cases reported through development studies with b...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvarani, Carlo, Sebastiani, Marco, Dieude, Philippe, Garcia, Miriam, Deberdt, Walter, Rogai, Veronica, de la Torre, Inmaculada, Inciarte-Mundo, José, Balsa, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380601/
https://www.ncbi.nlm.nih.gov/pubmed/34184191
http://dx.doi.org/10.1007/s40744-021-00332-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380601/
https://www.ncbi.nlm.nih.gov/pubmed/34184191
http://dx.doi.org/10.1007/s40744-021-00332-w

Ejemplares similares